Pasithea Therapeutics Corp
(KTTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 1,971 | 1,274 | 728 | 550 | 0 |
| Operating Income | -1,956 | -1,274 | -728 | -550 | N/A |
| Other Income | 2,586 | -253 | 0 | 0 | 0 |
| Pre-tax Income | 630 | -1,526 | -728 | -550 | 0 |
| Net Income Continuous | 630 | -1,526 | -728 | -550 | N/A |
| Net Income | $630 | $-1,526 | $-728 | $-550 | $N/A |
| EPS Basic Total Ops | 2.40 | -3.40 | -1.80 | -1.40 | N/A |
| EPS Basic Continuous Ops | 2.38 | -3.41 | -1.76 | -1.38 | N/A |
| EPS Diluted Total Ops | 2.40 | -3.40 | -1.80 | -1.40 | N/A |
| EPS Diluted Continuous Ops | 2.38 | -3.41 | -1.76 | -1.38 | N/A |
| EBITDA(a) | $-1,971 | $-1,274 | $-728 | $-550 | $N/A |